20 September 2023>: Clinical Research
Early Echocardiography and ECG Changes Following Radiotherapy in Patients with Stage II–III HER2-Positive Breast Cancer Treated with Anthracycline-Based Chemotherapy with or without Trastuzumab-Based Therapy
Radu Valeriu Toma 12ABCG , Zgura Anca 1E , Oana Gabriela Trifănescu 12A , Laurenţia Nicoleta Galeş 12D* , Antonia Ruxandra Folea 2CDEF , Loredana Stanca 3B , Liviu Bîlteanu 234ABCDEF* , Rodica M. Anghel 1ADOI: 10.12659/MSM.941754
Med Sci Monit 2023; 29:e941754
Supplementary Table 4 Tumor pre- and post-treatment staging and histology.
Characteristic | Value | N | % | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Tumor localization | Left | 48 | 70.6 | ||||||||
Right | 20 | 29.4 | |||||||||
Tumor (T) | T0 or Tx | 0 | 0.0 | 9 | 15.3 | ||||||
T1 | 6 | 9.1 | 23 | 39.0 | |||||||
T2 | 37 | 56.1 | 21 | 35.6 | |||||||
T3 | 11 | 16.7 | 3 | 5.1 | |||||||
T4 | 12 | 18.2 | 3 | 5.1 | |||||||
Missing | 2 | 9 | |||||||||
Nodal status (N) | N0 or Nx | 19 | 28.8 | 29 | 49.2 | ||||||
N1 | 35 | 53.0 | 19 | 32.2 | |||||||
N2 | 10 | 15.2 | 8 | 13.6 | |||||||
N3 | 2 | 3.0 | 3 | 5.1 | |||||||
Missing | 2 | 0 | |||||||||
0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 3 | 4.9 | ||
1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 3.3 | ||
1 | 3 | 0 | 2 | 1 | 1 | 1 | 0 | 9 | 14.8 | ||
1 | 2 | 0 | 7 | 4 | 3 | 0 | 3 | 0 | 32.8 | ||
1 | 6 | 0 | 4 | 2 | 1 | 0 | 0 | 14 | 23.0 | ||
2 | 1 | 1 | 3 | 1 | 2 | 2 | 1 | 13 | 21.3 | ||
6 | 14 | 1 | 18 | 8 | 7 | 3 | 4 | 61* | |||
9.8 | 23.0 | 1.6 | 29.5 | 13.1 | 11.5 | 4.9 | 6.6 | ||||
* Only the patients for whom we had pre-therapeutic and post-therapeutic staging data were included in this table. |